ABX Advanced Biochemical Compounds GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ABX Advanced Biochemical Compounds GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010857
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a biochemical compounds provider that manufactures, develops, and distributes biochemicals for nuclear medicine. The company’s products include PET and SPECT precursors and reference standards, reagents kits and cassettes, PET precursors and FDG reagents kits, custom synthesis, particularly kits, peptides, HCI, and radiotracers. It provides pharmaceutical kits and cassettes, APIs, ammpse triflate, precursors, glucose triflates, talose triflates, raclopride, tosyl fallypride, desmethoxyfallypride, fluoroethylspiperone, nitromazenil, flumazenil, harmol, harmine, and etomidate. The company also provides synthesis modules such as ORA NEPTIS mosaic-RS, SIEMENS Explora one, and ORA mosaic-LC and SCINTOMICS, among others. ABX is headquartered in Radeberg, Germany.

ABX Advanced Biochemical Compounds GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Endocyte Enters into Licensing Agreement with ABX 10
Equity Offering 11
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH – Key Competitors 13
ABX Advanced Biochemical Compounds GmbH – Key Employees 14
ABX Advanced Biochemical Compounds GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ABX Advanced Biochemical Compounds GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Endocyte Enters into Licensing Agreement with ABX 10
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH, Key Competitors 13
ABX Advanced Biochemical Compounds GmbH, Key Employees 14

★海外企業調査レポート[ABX Advanced Biochemical Compounds GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alviva Holdings Ltd (AVV):企業の財務・戦略的SWOT分析
    Alviva Holdings Ltd (AVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Advantage Oil & Gas Ltd (AAV):石油・ガス:M&Aディール及び事業提携情報
    Summary Advantage Oil & Gas Ltd (Advantage Oil & Gas) is an upstream company. It is involved in exploitation, acquisition, development, and production of crude oil, natural gas and natural gas liquids in Alberta. The company’s exploitation and development program is focused on Glacier assets and the …
  • Stantec Inc (STN)-石油・ガス分野:企業M&A・提携分析
    Summary Stantec Inc. (Stantec) is a consulting services company offering architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engineering, landscape architectu …
  • High Peak Royalties Ltd (HPR):石油・ガス:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Polo Resources Ltd (POL):石油・ガス:M&Aディール及び事業提携情報
    Summary Polo Resources Ltd (Polo Resources) is a natural resource and mine development investment company that evaluates, acquires, and develops substantial investments in companies and projects. The company also invests in exploration companies. It invests in the gold, oil and gas, coal, phosphate, …
  • Dart Group PLC:企業の戦略・SWOT・財務情報
    Dart Group PLC - Strategy, SWOT and Corporate Finance Report Summary Dart Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Legal & General Group Plc:企業のM&A・事業提携・投資動向
    Legal & General Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Legal & General Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Roland DG Corp (6789):企業の財務・戦略的SWOT分析
    Roland DG Corp (6789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Artizian Catering Services Limited:企業の戦略・SWOT・財務情報
    Artizian Catering Services Limited - Strategy, SWOT and Corporate Finance Report Summary Artizian Catering Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Snowy Hydro Ltd:電力:M&Aディール及び事業提携情報
    Summary Snowy Hydro Ltd (Snowy Hydro) is an integrated energy utility. It has presence in the energy vertical, from generating energy, providing price risk management products for wholesale customers, and delivering energy to homes and businesses. The company produces electricity from gas, hydro, an …
  • LifeScan Inc:企業の製品パイプライン分析
    Summary LifeScan Inc (LifeScan), a subsidiary of Platinum Equity LLC, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managemen …
  • Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析
    Summary Lansen Pharmaceutical Holdings Ltd (Lansen), a subsidiary of Cathay International Holdings Ltd is a pharmaceutical that develops, produces and sales specialty prescription western pharmaceuticals for the treatment of rheumatic diseases. The company’s products comprise specialist medicine, Ch …
  • University of Pennsylvania:企業のM&A・事業提携・投資動向
    University of Pennsylvania - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pennsylvania Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Codere S.A.:企業の戦略・SWOT・財務情報
    Codere S.A. - Strategy, SWOT and Corporate Finance Report Summary Codere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Intellect Design Arena Limited:戦略・SWOT・企業財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Silver Bull Resources, Inc.:企業の戦略・SWOT・財務分析
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Litani River Authority:企業の戦略的SWOT分析
    Litani River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bando Chemical Industries, Ltd. (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries, Ltd. (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆